Geode Capital Management’s Xenetic Biosciences XBIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $41.1K | Sell |
10,478
-475
| -4% | -$1.86K | ﹤0.01% | 4253 |
|
2025
Q1 | $28.6K | Sell |
10,953
-936
| -8% | -$2.45K | ﹤0.01% | 4287 |
|
2024
Q4 | $47.9K | Hold |
11,889
| – | – | ﹤0.01% | 4249 |
|
2024
Q3 | $52.1K | Sell |
11,889
-99
| -0.8% | -$434 | ﹤0.01% | 4261 |
|
2024
Q2 | $50.3K | Buy |
11,988
+990
| +9% | +$4.15K | ﹤0.01% | 4277 |
|
2024
Q1 | $41.5K | Hold |
10,998
| – | – | ﹤0.01% | 4359 |
|
2023
Q4 | $39.5K | Hold |
10,998
| – | – | ﹤0.01% | 4406 |
|
2023
Q3 | $53.8K | Buy |
+10,998
| New | +$53.8K | ﹤0.01% | 4404 |
|
2023
Q2 | – | Sell |
-91,545
| Closed | -$37.7K | – | 4783 |
|
2023
Q1 | $37.7K | Sell |
91,545
-798
| -0.9% | -$329 | ﹤0.01% | 4582 |
|
2022
Q4 | $26K | Sell |
92,343
-258
| -0.3% | -$73 | ﹤0.01% | 4729 |
|
2022
Q3 | $49K | Hold |
92,601
| – | – | ﹤0.01% | 4770 |
|
2022
Q2 | $74K | Buy |
92,601
+1,655
| +2% | +$1.32K | ﹤0.01% | 4683 |
|
2022
Q1 | $92K | Hold |
90,946
| – | – | ﹤0.01% | 4689 |
|
2021
Q4 | $117K | Sell |
90,946
-13,207
| -13% | -$17K | ﹤0.01% | 4673 |
|
2021
Q3 | $213K | Buy |
104,153
+53,643
| +106% | +$110K | ﹤0.01% | 4422 |
|
2021
Q2 | $103K | Buy |
50,510
+19,249
| +62% | +$39.3K | ﹤0.01% | 4551 |
|
2021
Q1 | $68K | Buy |
31,261
+18,077
| +137% | +$39.3K | ﹤0.01% | 4365 |
|
2020
Q4 | $26K | Buy |
+13,184
| New | +$26K | ﹤0.01% | 4231 |
|